ZOLGENSMA Trademark

Trademark Overview

On Monday, November 6, 2017, a trademark application was filed for ZOLGENSMA with the United States Patent and Trademark Office. The USPTO has given the ZOLGENSMA trademark a serial number of 87673650. The federal status of this trademark filing is REGISTERED as of Tuesday, October 29, 2019. This trademark is owned by AveXis, Inc.. The ZOLGENSMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
zolgensma

General Information

Serial Number87673650
Word MarkZOLGENSMA
Filing DateMonday, November 6, 2017
Status700 - REGISTERED
Status DateTuesday, October 29, 2019
Registration Number5897769
Registration DateTuesday, October 29, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 16, 2017
Primary Code005
First Use Anywhere DateMonday, June 10, 2019
First Use In Commerce DateMonday, June 10, 2019

Trademark Owner History

Party NameNOVARTIS AG
Party Type31 - New Owner After Registration
Legal Entity Type25 - NOT AVAILABLE
AddressBASEL 4002
CH
Party NameAveXis, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBannockburn, IL 60015
Party NameAveXis, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBannockburn, IL 60015
Party NameAveXis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBannockburn, IL 60015

Trademark Events

Event DateEvent Description
Monday, July 6, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Friday, July 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 3, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 1, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 29, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, September 26, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 25, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 16, 2019DATA MODIFICATION COMPLETED
Wednesday, August 14, 2019ASSIGNED TO LIE
Monday, August 5, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 19, 2019NON-FINAL ACTION E-MAILED
Friday, July 19, 2019SU - NON-FINAL ACTION - WRITTEN
Saturday, June 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 25, 2019USE AMENDMENT FILED
Friday, June 28, 2019SOU EXTENSION 2 GRANTED
Tuesday, June 25, 2019SOU EXTENSION 2 FILED
Friday, June 28, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 25, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019TEAS STATEMENT OF USE RECEIVED
Friday, January 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 9, 2019SOU EXTENSION 1 GRANTED
Wednesday, January 9, 2019SOU EXTENSION 1 FILED
Wednesday, January 9, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, July 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 15, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 23, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 23, 2018NON-FINAL ACTION E-MAILED
Friday, February 23, 2018NON-FINAL ACTION WRITTEN
Friday, February 16, 2018ASSIGNED TO EXAMINER
Thursday, November 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 9, 2017NEW APPLICATION ENTERED

Related Keywords

zolgensma preparations motor genetic nature therapy gene pharmaceutical containing neuron materials